Profile
YCBD ZTS TAK HLN TEVA ITCI
Company Name cbdMD, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $1.90M $73.21B $48.16B $45.90B $17.02B $14.00B
Employees 0.04K 13.80K 49.28K 24.56K 33.89K 0.86K
CEO Mr. T. Ronan Kennedy Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
YCBD ZTS TAK HLN TEVA ITCI
Last Close $0.2594 $159.61 $15.19 $10.45 $14.85 $131.87
High 52 $1.1 $196.48 $15.19 $10.69 $22.77 $131.91
Low 52 $0.23 $145.54 $12.6 $8.01 $12.78 $64.76
Price vs. 52 Week High -76.42 % -18.77 % 0 % -2.25 % -34.78 % -0.03 %
Price vs. 52 Week Low 12.78 % 9.67 % 20.56 % 30.46 % 16.2 % 103.63 %
Total Return
YCBD ZTS TAK HLN TEVA ITCI
1 Month Return -25.89 % -6.06 % 2.29 % -2.06 % -5.35 % 0.48 %
3 Month Return -55.08 % -2.27 % 14.56 % 10.47 % -30.08 % 57.51 %
6 Month Return -44.98 % -16.01 % 5.27 % 0.77 % -15.09 % 80.92 %
9 Month Return -56.76 % -9.52 % 16.18 % 23.52 % -11.32 % 90.92 %
YTD Return -30.83 % -2.04 % 14.73 % 9.54 % -32.62 % 57.89 %
1 Year Return -73.02 % -3.57 % 12.69 % 26.97 % 6.6 % 96.21 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
YCBD ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.1 % 4.23 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -2.09 % 2.05 % 1.76 % - 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.8 % 192 % 0.02 % - -
Payout Ratio (TTM) - 31.62 % 145.09 % - - -
Profitability
YCBD ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 66.48 % 69.85 % 54.74 % 61.52 % 48.74 % 91.63 %
Return on Assets TTM -31.96 % 17.46 % 1.38 % 4.2 % -4.17 % -5.46 %
Return on Equity TTM -149.66 % 49.65 % 2.83 % 8.73 % -26.15 % -7.4 %
Return on Capital Employed TTM -3730.09 % 24.27 % 3.62 % 7.74 % -1.14 % -10.05 %
Net Income Per EBT TTM -29.77 % 79.35 % 89.75 % 75.5 % 127.75 % 100.64 %
EBT Per Ebit TTM -14 % 119.26 % 49.18 % 86.58 % 423.43 % 63.57 %
EBIT Per Revenue TTM -1.73 % 28.38 % 10.3 % 19.64 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -34.75 % 43.79 % 22.2 % - 6.9 % -430.93 %
Receivables Turnover TTM 4028.44 7.03 6.23 - 5.41 4.09
Payables Turnover TTM 1480.05 6.45 4.5 2.19 3.85 2.18
Inventory Turnover TTM 812.11 1.21 1.66 3.63 2.82 2.17
Fixed Asset Turnover TTM 287426.84 % 256.4 % 226.93 % 584.75 % 334.34 % 4569.25 %
Asset Turnover TTM 44421.67 % 65.01 % 30.31 % 32.73 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -0.12 6.5 678.77 - 1.1 -0.71
Free Cash Flow Per Share TTM -0.18 5.06 484.07 - 0.66 -0.71
Cash Per Share TTM 43.28 % 437.03 % 33271.95 % 24.05 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -0.01 % 31.9 % 23.47 % - 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 147.76 % 77.82 % 71.32 % - 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -34.75 % 43.79 % 22.2 % - 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM -2.28 31.86 9.39 - 22.99 -190.53
Price To Operating Cash Flows Ratio TTM -2.44 25.15 6.69 - 13.65 -185.61
Price Cash Flow Ratio TTM -2.44 25.15 6.69 - 13.65 -185.61
Income Statement (TTM)
YCBD ZTS TAK HLN TEVA ITCI
Revenue $0.02B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.01B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 61.57% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $-0B $3.86B $874.6B $2.51B $-0.3B $-0.12B
Net Income $-0B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted 1.93 5.47 91.16 0.16 -1.45 -0.72
Balance Sheet (MRQ)
YCBD ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.71B $16.3B $0.01B
Total Liabilities $0.01B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $0B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0B $6.74B $4843.75B $10.29B $18.08B $0.02B
Total Assets $0.01B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
YCBD ZTS TAK HLN TEVA ITCI
Net Income $-0B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.01
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.235
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.505
ALVOW Alvotech 1.11
AMPH Amphastar Pharmaceuticals, Inc. 26.6
AMRX Amneal Pharmaceuticals, Inc. 7.385
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 67.45
AQST Aquestive Therapeutics, Inc. 2.715
ASRT Assertio Holdings, Inc. 0.6298
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 6.82
AYTU Aytu BioPharma, Inc. 1.05
ETFs With Exposure to YCBD
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 248.53
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 110.28
VXF Vanguard Extended Market Index Fund 0 155.29
THCX The Cannabis ETF 1.83 16.5963
POTX Global X Cannabis ETF 0.02 5.15
TOKE Cambria Cannabis ETF 1.56 4.02
CNBS Amplify Growth Opportunities ETF 0 14.985
YOLO AdvisorShares Pure Cannabis ETF 0.02 1.57
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 124.4
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 124.41
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 306.98
Unlock